Design, synthesis, and biological evaluation of novel pyrazolo [3,4-d]pyrimidine derivatives as potent PLK4 inhibitors for the treatment of TRIM37-amplified breast cancer-Reference-Cited by-同舟云学术

Design, synthesis, and biological evaluation of novel pyrazolo [3,4-d]pyrimidine derivatives as potent PLK4 inhibitors for the treatment of TRIM37-amplified breast cancer

Published:2022-08 Issue: Volume:238 Page:114424
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Sun Yin,Sun Yu,Wang Lin,Wu Tianxiao,Yin Wenbo,Wang Jingkai,Xue Yanli,Qin Qiaohua,Sun Yixiang,Yang Huali,Zhao Dongmei,Cheng Maosheng

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference35 articles.

1. Understanding the polo kinase machine;Archambault;Oncogene,2015

2. Non-mitotic functions of polo-like kinases in cancer cells;Raab;Biochim. Biophys. Acta Rev. Canc,2021

3. Emerging insights into symmetry breaking in centriole duplication: updated view on centriole duplication theory;Yamamoto;Curr. Opin. Struct. Biol.,2021

4. PLK4: a promising target for cancer therapy;Zhao;J. Cancer Res. Clin. Oncol.,2019

5. PLK4: a link between centriole biogenesis and cancer;Maniswami;Expert Opin. Ther. Targets,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QSAR, molecular docking, and dynamics-based computational discovery of potential PLK4 inhibitors for tumor therapy;Process Biochemistry;2024-11

2. Progress with polo-like kinase (PLK) inhibitors: a patent review (2018–present);Expert Opinion on Therapeutic Patents;2024-07-15

3. Current scenario of pyrazole hybrids with anti‐breast cancer therapeutic applications;Archiv der Pharmazie;2024-06-29

4. Design of novel PLK4 inhibitors as TRIM37-amplified breast cancer drugs using 3D-QSAR, molecular docking, and molecular dynamics simulation methods;Molecular Simulation;2024-04-04

5. Therapeutic potential of targeting polo-like kinase 4;European Journal of Medicinal Chemistry;2024-02